Lineage Cell Therapeutics, Inc. (LCTX.TA)

ILA 191.3

(5.4%)

Long Term Debt Summary of Lineage Cell Therapeutics, Inc.

  • Lineage Cell Therapeutics, Inc.'s latest annual long term debt in 2023 was 2.07 Million USD , down -29.69% from previous year.
  • Lineage Cell Therapeutics, Inc.'s latest quarterly long term debt in 2024 Q2 was 1.83 Million USD , down 0.0% from previous quarter.
  • Lineage Cell Therapeutics, Inc. reported annual long term debt of 2.94 Million USD in 2022, up 49.37% from previous year.
  • Lineage Cell Therapeutics, Inc. reported annual long term debt of 1.97 Million USD in 2021, down -22.4% from previous year.
  • Lineage Cell Therapeutics, Inc. reported quarterly long term debt of 1.83 Million USD for 2024 Q2, down 0.0% from previous quarter.
  • Lineage Cell Therapeutics, Inc. reported quarterly long term debt of 2.07 Million USD for 2023 FY, down -29.69% from previous quarter.

Annual Long Term Debt Chart of Lineage Cell Therapeutics, Inc. (2023 - 1991)

Historical Annual Long Term Debt of Lineage Cell Therapeutics, Inc. (2023 - 1991)

Year Long Term Debt Long Term Debt Growth
2023 2.07 Million USD -29.69%
2022 2.94 Million USD 49.37%
2021 1.97 Million USD -22.4%
2020 2.54 Million USD -35.61%
2019 3.94 Million USD 101.48%
2018 1.95 Million USD 67.49%
2017 1.16 Million USD -58.95%
2016 2.84 Million USD -42.7%
2015 4.97 Million USD 1114.35%
2014 409.27 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%
2005 - USD 0.0%
2004 - USD 0.0%
2003 - USD -100.0%
2002 2.16 Million USD 25.28%
2001 1.73 Million USD 0.0%
2000 - USD 0.0%
1999 - USD 0.0%
1998 - USD 0.0%
1996 - USD 0.0%
1995 - USD 0.0%
1994 - USD 0.0%
1993 - USD 0.0%
1992 - USD 0.0%
1991 - USD 0.0%

Peer Long Term Debt Comparison of Lineage Cell Therapeutics, Inc.

Name Long Term Debt Long Term Debt Difference
Matricelf Ltd - ILA -Infinity%